They may be contraindicated with other medications
Their ease of use and ability to act systemically make them a convenient option for research and therapeutic purposes
In 2009, the first glucagon and GLP-1 receptor co-agonist was reported, which combined action profiles of two gastrointestinal hormones within a single molecule achieving a synergistic glucose-lowering and weight loss benefit
Chronic GH secretion suppresses the anti-lipolytic action of insulin and increases FFA flux into the systemic circulation, thereby promoting lipotoxicity, which causes pathophysiological problems, including insulin resistance [10]
A comprehensive review of molecular hydrogen as a novel nutrition therapy in relieving oxidative stress and diseases: mechanisms and perspectives
Be sure to consult a healthcare provider before receiving any IV therapy, especially if you have underlying health conditions